Share: Facebook Twitter LinkedIn
Activity Provided By:

Paradigm Medical Communications, LLC.

Psoriasis Prime Time: TYK Inhibition in Hard-to-Treat Psoriasis

Access Activity

Overview / Abstract:

Target Audience
This activity has been designed to address the educational needs of dermatologists, dermatology nurse practitioners, and PAs. It may also be of benefit to primary care clinicians, rheumatologists, and other healthcare practitioners who are interested in the treatment of psoriasis.

Program Overview
In this edition of Psoriasis Prime Time, the faculty reviews the use of allosteric tyrosine kinase 2 (TYK2) inhibitors in the treatment of hard-to-treat psoriasis, including the rationale for TYK2 inhibition and clinical data associated with TYK2 inhibitors in psoriasis and emerging data in psoriatic arthritis (PsA). In addition, screening for PsA and use of systemic treatments to reduce joint symptoms are discussed.

Learning Objectives
Upon completion of this activity, participants should be able to:

Describe how allosteric inhibition of TYK2 confers efficacy and safety in psoriasis
Outline the safety, efficacy, and role of TYK2 inhibition in psoriatic disease management
Devise patient-centric, evidence-based treatment plans for patients with psoriasis

Expiration

Jul 31, 2025

Discipline(s)

Physician CME

Format

Online

Credits / Hours

0.5 AMA PRA Category 1 Credit

Presenters / Authors / Faculty

Faculty
April W. Armstrong, MD, MPH
April W. Armstrong, MD, MPH
Professor and Chief of Dermatology
University of California Los Angeles
Los Angeles, CA

Rishi P. Singh, MD
Amit Garg, MD
Professor and Founding Chair
Department of Dermatology
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Professor, Center for Health Innovations and Outcomes Research
Feinstein Institutes for Medical Research
Hempstead, NY

Mio Nakamura, MD, MS
Mio Nakamura, MD, MS
Assistant Professor
Dermatology
University of Michigan
Ann Arbor, MI

Sponsors / Supporters / Grant Providers

Bristol Myers Squibb Company.

Keywords / Search Terms

Relias LLC Relias LLC., FreeCME., Psoriasis Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map